Module

The Paradox of Treating Liver Disease With Potentially Hepatotoxic Drugs

Source: Hepatitis Annual Update 2006

The Paradox of Treating Liver Disease With Potentially Hepatotoxic Drugs

Program Director: Emmet B. Keeffe, MD, MACP

Faculty:

Eugene R. Schiff, MD, MACP, FRCP, MACG
Ronald Concha, MD

CREDIT INFORMATION

Release Date: July 03, 2006

Expiration Date: July 02, 2007

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.1 Nursing contact hours

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Review the impact of hepatotoxic drugs on the liver
Discuss the effect of statins, thiazolidinediones, and other lipid-lowering and antiglycemic agents on liver disease
Describe the impact of acetaminophen on liver disease

Topics covered include:

Introduction
Drug-Induced Liver Injury
Statins and Liver Toxicity
Statins: The Effect of Baseline Liver Enzyme Elevation
Statins and Liver Disease
Fibrates
Thiazolidinediones for NAFLD
Metformin
Acetaminophen and Liver Disease
Conclusion

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.